We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CNTGF

Price
0.14
Stock movement up
+- (%)
Company name
Centogene N.V.
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Diagnostics & Research
Markedsverdi
2.06M
Ent verdi
-
Pris/omsetning
-
Pris/bok
-
Utbytte avkastning
-
Utbytte vekst
-
Vekst år
-
FCF-utbetaling
-
Etterfølgende P/E
-
Fremtidig P/E
-
PEG
-
EPS-vekst
-
1 års avkastning
-66.19%
3 års avkastning
-64.74%
5 års avkastning
-64.17%
10 års avkastning
-
Sist oppdatert: 2025-09-12

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UTBYTTE

CNTGF betaler ikke utbytte

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VERDSETTELSE

Verdsettelsesforhold

Loading...
Verdsettelsesforhold-data
Etterfølgende P/E-
Pris til OCF-
Pris til FCF-
Pris til EBITDA-
EV i forhold til EBITDA-

Verdsettelse (Salg/Bokført verdi)

Loading...
Verdsettelse (Salg/Bokført verdi) data
Pris til omsetning-
Pris til bok-
EV i forhold til salg-

ØKONOMI

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

AKSJEINFORMASJON

Aksjediagram

Loading...
Aksjekurs-data
Åpning0.07
Daglig høy0.07
Daglig lav0.07
Daglig volum0K
Tidenes høyeste25.16
1 år analytikerestimat1.50
Beta-0.02
EPS (TTM)-
Utbytte per aksje-
Ex-div dato-
Neste dato for resultatpresentasjon-

Nedsidepotensial

Loading...
Nedsidepotensial-data
CNTGFS&P500
Nåværende prisfall fra toppnotering-99.72%-1.46%
Høyeste prisfall-99.96%-56.47%
Dato for høyeste fall28 Jul 20259 Mar 2009
Gj.snittlig fall fra topp-76.81%-10.99%
Gj.snittlig tid til ny topp132 days12 days
Maks tid til ny topp1292 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

SELSKAPSOPPLYSNINGER
CNTGF (Centogene N.V.) company logo
Markedsverdi
2.06M
Markedsverdi kategori
Small-cap
Beskrivelse
Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service platform, which enables laboratories to analyze, interpret, and report genomic variants for rare disease diagnostics; FilterTool, a web-based application for genetic data interpretation; and NEW CentoGenome, a Next Generation Sequencing (NGS)-based assay that provides diagnostic information to accelerate access to potential treatment options. The company also offers target and drug screening, clinical development, and market access and expansion, as well as CENTOGENE Biodatabank licenses and insight reports. In addition, it provides early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services, such as whole exome sequencing, whole genome sequencing, and multiomic testing solutions to physicians, laboratories, and hospitals directly or through distributors. The company was founded in 2006 and is headquartered in Rostock, Germany.
Ansatte
384
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Land
USA
By
Aksjetype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...

iO Charts is a Seeking Alpha partner

FORSTÅ VIRKSOMHETEN
Loading...